Core Viewpoint - Anhui Qianfang Lianlu Intelligent Technology Co., Ltd. has been established with a registered capital of 50 million yuan, focusing on IoT technology services and AI software development [1] Group 1: Company Overview - The legal representative of the newly established company is Hua Zhongnan [1] - The company is wholly owned by Lianlu Intelligent Technology (Shanghai) Co., Ltd. [1] Group 2: Shareholding Structure - Lianlu Intelligent Technology (Shanghai) Co., Ltd. is jointly held by Qianfang Technology (002373) and China Unicom Zhinet Technology Co., Ltd. among others [1]

Group 1 - The core viewpoint of the news is that Qianfang Technology has shown significant trading activity and financial performance, with a notable increase in stock price and financing activities on December 19 [1] - On December 19, Qianfang Technology's stock price increased by 5.36%, with a trading volume of 730 million yuan, and a net financing purchase of 29.64 million yuan [1] - As of December 19, the total balance of margin trading for Qianfang Technology reached 761 million yuan, with a financing balance of 759 million yuan, accounting for 4.29% of the circulating market value [1] Group 2 - As of November 28, the number of shareholders for Qianfang Technology was 88,900, a decrease of 1.54% from the previous period, while the average circulating shares per person increased by 1.57% to 15,493 shares [2] - For the period from January to September 2025, Qianfang Technology reported a revenue of 5.256 billion yuan, a year-on-year decrease of 2.82%, while the net profit attributable to shareholders increased by 1,098.97% to 189 million yuan [2] - Since its A-share listing, Qianfang Technology has distributed a total of 602 million yuan in dividends, with 78.84 million yuan distributed over the past three years [3]

Investment Rating - The report assigns a "Buy" rating for the computer industry, consistent with the previous rating [2]. Core Insights - The report highlights the significant growth in the usage of the Doubao large model, with daily token usage surpassing 50 trillion, reflecting a 417-fold increase since its launch [14][47]. - The competitive landscape is shifting from business model innovation to hard technology capabilities, emphasizing the importance of foundational research and engineering in AI development [5]. - The integration of AI capabilities into various applications, such as travel planning and local services, is expected to benefit companies involved in AI chips, servers, and foundational software tools [24]. Summary by Sections 1. Doubao Large Model Token Growth - The Doubao large model's daily token usage has exceeded 50 trillion, marking a significant increase from 30 trillion in September 2025, with a monthly growth rate of 22% [14][15]. - The model's commercial viability is improving as the cost of reasoning decreases, with the latest version, Doubao 1.8, optimizing for multi-modal tasks and reducing redundant computational costs [15][20]. 2. Performance Enhancements of Doubao Large Model - The Doubao 1.8 model has shown substantial improvements in multi-modal understanding and task execution, outperforming competitors like Qwen3 in various metrics [27][32]. - New models such as Seedance 1.5 Pro and Seedream 4.5 have been introduced, enhancing capabilities in video generation and image creation, respectively [33][43]. 3. Integration of Qianwen APP with Gaode - The Qianwen APP has integrated with Gaode, enabling it to transition from understanding user intent to executing real-world services, significantly enhancing user experience in travel and local services [56][58]. - The app's public testing has resulted in rapid user adoption, with over 3 million active users within 23 days of launch [53]. 4. Investment Recommendations - Companies expected to benefit from the increase in reasoning-side computational power include AI chip and server firms like Cambricon, Inspur, and Unisoc, as well as foundational software companies like Fourth Paradigm and StarRing Technology [24].

（文章来源：证券日报） 证券日报网讯 12月17日晚间，千方科技发布公告称，截至本公告披露日，公司已全额归还暂时补充流 动资金的闲置募集资金，上述闲置募集资金暂时补充流动资金及归还事项实施完毕。 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京千方科技股份有限公司（以下简称"公司"）于2024年12月20日召开第六 届董事会第八次会议和第六届监事会第七次会议，审议通过了《关于使用部分闲 置募集资金暂时补充流动资金的议案》，同意公司使用70,000万元的部分闲置募 集资金暂时补充流动资金，用于主营业务相关的生产经营使用，使用期限自董事 会审议批准该议案之日起不超过12个月。详细内容请见公司于2024年12月21日在 《中国证券报》、《上海证券报》、《证券日报》、《证券时报》和巨潮资讯网 （www.cninfo.com.cn）上披露的《关于使用部分闲置募集资金暂时补充流动资金 的公告》（公告编号：2024-056）。 2025年6月12日，公司将使用的40,000万元闲置募集资金归还至公司募集资 金专用账户，使用期限未超过12个月，并将上述归还情况通知了保荐机构及保荐 代表人。 2025年12月17日，公司将使用的30,000万元闲置募集资金归还至公司募集资 金专用账户，使用期限未超过12个月，并将上述归还情况通知了保荐机构及保荐 代表人。 证券代码： ...

Investment Rating - The report maintains a "Recommended" rating for the industry, indicating an expected stock price increase of over 15% relative to the benchmark index within the next 12 months [2][7]. Core Insights - The approval of the first batch of L3 conditional autonomous driving vehicles in China marks a significant step towards commercialization, with two models set to begin trials in designated areas of Beijing and Chongqing [1][5]. - The report highlights that multiple domestic automakers, including Changan, BYD, and GAC, have made substantial progress in the L3 autonomous driving sector, with several models receiving road testing permits [5]. - The report emphasizes the importance of the L3 level autonomous driving technology in enhancing road safety and the need for regulatory improvements in traffic laws and insurance [5]. Summary by Sections Industry Overview - The Ministry of Industry and Information Technology has granted conditional approval for L3 autonomous driving vehicles, allowing for specific operational scenarios in urban and highway settings [1][5]. - The report notes that the L3 vehicles can operate at speeds of up to 80 km/h in designated areas, with specific routes identified for testing in Chongqing and Beijing [5]. Market Development - The report identifies a turning point for the industry, as several companies are actively developing L3 technology, with notable advancements from firms like Huawei and GAC [5]. - The report suggests that the commercialization of L3 autonomous driving will significantly impact the overall development of the autonomous driving industry in China [5]. Investment Recommendations - The report recommends focusing on companies involved in the autonomous driving sector, including companies like Zhongke Chuangda, Siwei Tuxin, and others, as they are expected to benefit from the advancements in L3 technology [5].

Core Viewpoint - The market for high-precision AI solutions is experiencing explosive growth, with a projected increase from RMB 47.7 billion in 2019 to RMB 222.5 billion by 2024, reflecting a compound annual growth rate of 36.1% [3]. Company Overview - Wisdom Interconnect Technology Co., Ltd. focuses on AI technology and spatial intelligence solutions, particularly in urban traffic management, utilizing computer vision and multimodal perception technologies [3]. - The company has been preparing for an IPO since 2021 and has recently submitted its application to the Hong Kong Stock Exchange after several previous attempts [3]. Market Position - Wisdom Interconnect ranks fourth among spatial intelligence solution providers in China's smart transportation sector, holding a market share of 6.6%, and is the leading provider of roadside spatial intelligence solutions with a 19.3% market share [5][6]. - The company has attracted investments from notable entities such as Xiaomi Group, NIO, and various venture capital firms [5]. Financial Performance - Revenue figures for Wisdom Interconnect during the reporting period are as follows: RMB 538 million in 2022, RMB 618 million in 2023, RMB 699 million in 2024, and RMB 103 million in the first half of 2025, with corresponding gross profits of RMB 128 million, RMB 154 million, RMB 209 million, and RMB 13.54 million [7]. - The company has reported continuous net losses totaling RMB 1.172 billion over the past three and a half years, primarily due to changes in the fair value of financial instruments [7]. Revenue Composition - The primary revenue source for Wisdom Interconnect is its roadside spatial intelligence solutions, with revenue contributions of 42.2%, 46%, 66.8%, and 87.1% across the reporting periods [8][9]. - The competitive landscape in the smart parking sector is intense, with numerous brands emerging, indicating no single dominant player [8]. Customer Dynamics - The number of clients has decreased from 257 to 59 over the reporting period, while the concentration of revenue from major clients has increased significantly [10]. - Despite the decline in total clients, the number of long-term stable clients has risen from 9 in 2022 to 30 in the first half of 2025, indicating a shift towards more sustainable relationships [10].

本报讯（记者王斌）北京青年报记者昨天了解到，海淀区人才工作局近日联合中关村科学城公司组团参 展"创新香港国际人才嘉年华"，集中发布近200家科创企业的1000余个岗位需求，涵盖人工智能、具身 智能、海外市场拓展等多个核心领域，为京港两地科技人才深度对接搭建高效平台，推动区域科创协同 再升级。 企业方同样收获颇丰。多家参展企业表示，本次活动候选人中硕士及以上学历、跨文化背景者占比显著 提升，招聘匹配效率大幅增强，为企业布局海外市场、组建跨文化团队提供了直接支撑。现场，海淀人 才工作局工作人员还同步开展政策解读与就业指导，帮助香港人才快速了解区域发展优势。 此次海淀展团带来的岗位覆盖研发、算法工程、国际商务等方向，银河通用、千方科技、声智科技等重 点企业现场设展纳才，吸引香港大学、香港中文大学及欧美高校的博士、硕士等青年科研人才扎堆咨 询。"海淀企业从上市公司到成长型团队都有，既能满足专业深耕需求，又有跨场景发展空间。"香港中 文大学应届毕业生的评价，道出了众多求职者的心声。 据了解，"创新香港国际人才嘉年华"自2018年起已累计吸引超10万名海内外专业人才参与，成为大湾区 链接全球人才的重要枢纽。此次海淀区又主 ...

Group 1: National Medical Insurance Directory Inclusion - Heng Rui Medicine has multiple drugs included in the 2025 National Medical Insurance Directory [1] - Xing Qi Eye Medicine has 39 products continuing to be included in the National Medical Insurance Drug Directory [1] - Bei Da Pharmaceutical has four products included in the National Medical Insurance Drug Directory [1] - Junshi Biosciences has added indications for Tuoyi® and included Junshida® in the National Medical Insurance Directory [1] - Zhongsheng Pharmaceutical's innovative drug Angladiwei tablets have been included in the National Medical Insurance Directory through negotiation [1] - Yiling Pharmaceutical's subsidiary has its exclusive product Qifang Nasal Tablets included in the National Medical Insurance Directory, totaling 12 exclusive patented traditional Chinese medicine products [1] - Aosaikang's product Liratinib tablets (Aoyi Xin®) has been included in the 2025 National Medical Insurance Directory [1] - Kanghong Pharmaceutical's product Kangbai Xip eye injection (Langmu) has been included in the 2025 National Medical Insurance Directory [1] - Dongcheng Pharmaceutical's Technetium-99m injection has been included in the medical insurance directory; its subsidiary has received clinical trial approval for 177Lu-LNC1009 injection [1] - Micron Biomedical's Sidabena tablets have been included in the National Medical Insurance Directory for regular Class B management [1] - Haichuang Pharmaceutical's Deuteroenzalutamide soft capsules have been included in the National Medical Insurance Directory for the first time [1] - Huadong Medicine's subsidiary products and cooperative products have been included in the National Medical Insurance and commercial insurance innovative drug directory [1] - Aidi Pharmaceutical's two anti-HIV innovative drugs continue to be included in the National Medical Insurance Directory through a simplified renewal process [1] Group 2: Corporate Developments - Hengyin Technology has signed a cooperation agreement with Muxi Co., focusing on the domestic GPU scenario [1] - Jia Jian Co. is planning a change in control, with stock resuming trading on December 8 [2] - Gu Ao Technology's actual controller is planning a change in control, leading to stock suspension [2] Group 3: Financial Performance - Tianbang Food reported a commodity pig sales revenue of 654 million yuan in November, a month-on-month increase of 7.66% [3] - Tian Ci Materials' controlling shareholder has committed not to reduce company shares [3]

Core Viewpoint - Qianfang Technology disclosed that as of September 30, 2025, the company's inventory book value is 262,302 million yuan, primarily consisting of equipment, components, materials for project contracts, as well as raw materials, semi-finished products, and finished goods necessary for production [2] Group 1 - The inventory book value of Qianfang Technology is 262,302 million yuan [2] - The majority of the inventory consists of project contract preparations, including equipment, components, and materials [2] - The inventory also includes raw materials, semi-finished products, and finished goods required for production [2]